Pancreatic Cancer Research

ResearcherSheng Jing HospitalActive in the last 2 years

Wenyang Zhou

Matched on ORCID iD 0000-0002-3676-0584; OpenAlex author ID A5065919151. Sources: OpenAlex.

Their work

Papers
8 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
10
Papers, trials and grants by year

2019: 2 papers · 2020: none · 2021: 1 paper · 2022: none · 2023: 3 papers · 2024: 2 papers

Papers 8

  1. PELI1 overexpression contributes to pancreatic cancer progression through upregulating ubiquitination-mediated INPP5J degradation. Co-author DOI 10.1016/j.cellsig.2024.111194↗
  2. HTF4 modulates the transcription of GID2 to promote the malignant biological behavior of pancreatic cancer. Co-author DOI 10.1016/j.pan.2024.08.008↗
  3. Aberrant expression of PELI1 caused by Jagged1 accelerates the malignant phenotype of pancreatic cancer. Co-author DOI 10.1016/j.cellsig.2023.110877↗
  4. GID2 Interacts With CDKN3 and Regulates Pancreatic Cancer Growth and Apoptosis. Co-author DOI 10.1016/j.labinv.2023.100122↗
  5. PSMD12 interacts with CDKN3 and facilitates pancreatic cancer progression. First author DOI 10.1038/s41417-023-00609-y↗
  6. SHP1 Decreases Level of P-STAT3 (Ser727) and Inhibits Proliferation and Migration of Pancreatic Cancer Cells. Co-author DOI 10.1615/jenvironpatholtoxicoloncol.2020035980↗
  7. Long noncoding RNA LINC00473 drives the progression of pancreatic cancer via upregulating programmed death-ligand 1 by sponging microRNA-195-5p. Co-author DOI 10.1002/jcp.28884↗
  8. Long non-coding RNA LINC01207 silencing suppresses AGR2 expression to facilitate autophagy and apoptosis of pancreatic cancer cells by sponging miR-143-5p. Co-author DOI 10.1016/j.mce.2019.04.004↗

Closest collaborators

The 10 strongest of 10 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Xiangpeng Meng · 5 shared papers, 2023–2024 · strength 1.19
  2. Jia Ma · 4 shared papers, 2023–2024 · strength 0.97
  3. Xin Deng · 3 shared papers, 2023–2024 · strength 0.73
  4. Baosheng Wang · 3 shared papers, 2023 · strength 0.68
  5. Xianghong Yang · 3 shared papers, 2019–2021 · strength 0.37
  6. Baosheng Wang · 1 shared paper, 2024 · strength 0.26
  7. Chang Liu · 2 shared papers, 2019 · strength 0.22
  8. Mingming Zhang · 2 shared papers, 2019 · strength 0.22
  9. Jia Ma · 1 shared paper, 2023 · strength 0.22
  10. Mingming Zhang · 1 shared paper, 2021 · strength 0.15

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.